CASP2
CASP2 (caspase 2) is a cysteine-aspartic acid protease of the caspase family that acts in cell death and cell cycle pathways. It is also known as ICH1, NEDD2 and PPP1R57, and UniProt notes it may function as an endogenous apoptosis inhibitor. Browse Assay Genie's current range of CASP2 research reagents below, or read on for the biology behind the target.
CASP2 belongs to the cysteine-aspartic acid protease (caspase) family, whose members mediate apoptosis through proteolytic cleavage of specific protein substrates. The enzyme is classed as EC 3.4.22.55 and sits in the peptidase C14A family. According to NCBI Gene, the encoded protein may function in stress-induced cell death pathways, cell cycle maintenance and the suppression of tumorigenesis. UniProt adds that it may act as an endogenous apoptosis inhibitor that antagonises caspase activation and cell death, so its role in cell fate may depend on context.
The CASP2 gene encodes the caspase-2 protein, with orthologues named Casp2 in both mouse and rat. Alternatively spliced transcript variants encoding multiple isoforms have been observed. HGNC places the gene in several groups: caspases, caspase recruitment domain (CARD) containing proteins, protein phosphatase 1 regulatory subunits (hence the alias PPP1R57), and the caspase-2 PIDDosome complex.
The gene was originally named NEDD2, for neural precursor cell expressed, developmentally down-regulated 2, and later renamed caspase 2, apoptosis-related cysteine peptidase. Other aliases include ICH1 and MGC2181. NCBI Gene reports that increased expression of this gene may play a role in neurodegenerative disorders, including Alzheimer's disease, Huntington's disease and temporal lobe epilepsy. Researchers studying CASP2 often compare it with other caspases to separate its functions from those of the better characterised apoptotic proteases.
CASP2 is a caspase family protease implicated in stress-induced cell death pathways, and it may also act as an endogenous inhibitor of apoptosis.
Increased CASP2 expression may play a role in Alzheimer's disease, Huntington's disease and temporal lobe epilepsy.
NCBI Gene reports that CASP2 may contribute to cell cycle maintenance, linking a protease to proliferation control.
The protein may function in the suppression of tumorigenesis, making CASP2 relevant to studies of cancer and cell death.
CASP2 encodes caspase-2, a cysteine-aspartic acid protease. Caspases mediate apoptosis by cleaving specific protein substrates. CASP2 may act in stress-induced cell death, cell cycle maintenance and tumour suppression, and UniProt notes it may also function as an endogenous apoptosis inhibitor.
CASP2 is also known as ICH1, NEDD2, PPP1R57 and MGC2181. NEDD2 comes from the earlier name neural precursor cell expressed, developmentally down-regulated 2. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
Mouse and rat both have a Casp2 orthologue. NCBI Gene reports that increased CASP2 expression may play a role in Alzheimer's disease, Huntington's disease and temporal lobe epilepsy. Check the datasheet of any product for its validated reactivity.
Other caspase family proteases and related apoptosis targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P42575; product specifications from Assay Genie datasheets.